ArticleBlood2024
Ready, AIM, stop: ibrutinib plus venetoclax in MCL.
Danielle S Wallace et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBlood2024
Danielle S Wallace et al.PubMed ↗Publisher ↗
No numbers read from the abstract.